Form4insider filings, from the source

SEC Form 4 · accession 0001179110-16-018859

Editas Medicine, Inc. · EDIT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Noubar Afeyan
10% Owner
Period of report
Feb 8, 2016
Accepted (ET)
Feb 9, 2016 · 6:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Feb 8, 2016C2,039,549—A2,039,549D
Common StockF1,F2Feb 8, 2016C1,617,015—A3,656,564D
Common StockF1,F2Feb 8, 2016C307,692—A3,964,256D
Common StockF1,F3Feb 8, 2016C509,885—A509,885ISee Footnote
Common StockF1,F3Feb 8, 2016C404,253—A914,138ISee Footnote
Common StockF1,F3Feb 8, 2016C76,922—A991,060ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A-1 Preferred StockF2,F1—Feb 8, 2016C5,302,834D——Common Stock2,039,5490D
Series A-2 Preferred StockF2,F1—Feb 8, 2016C4,204,240D——Common Stock1,617,0150D
Series B Preferred StockF2,F1—Feb 8, 2016C800,001D——Common Stock307,6920D
Series A-1 Preferred StockF3,F1—Feb 8, 2016C1,325,708D——Common Stock509,8850I
Series A-2 Preferred StockF3,F1—Feb 8, 2016C1,051,060D——Common Stock404,2530I
Series B Preferred StockF3,F1—Feb 8, 2016C199,999D——Common Stock76,9220I

Explanation of responses